Intravascular ultrasound-derived stent dimensions as predictors of angiographic restenosis following nitinol stent implantation in the superficial femoral artery

Journal of Endovascular Therapy

Volumn 23, Issue 3, 2016, Pages 424-432

  Miki, Kojiro ^a   Fujii, Kenichi ^b   Kawasaki, Daizo ^c   Shibuya, Masahiko ^b   Fukunaga, Masashi ^c   Imanaka, Takahiro ^b   Tamaru, Hiroto ^b   Sumiyoshi, Akinori ^b   Nishimura, Machiko ^b   Horimatsu, Tetsuo ^b   Saita, Ten ^b   Okada, Kozo ^a   Kimura, Takumi ^a   Honda, Yasuhiro ^a   Fitzgerald, Peter J ^a   Masuyama, Tohru ^b   Ishihara, Masaharu ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Angioplasty; Drug eluting stent; Endovascular therapy; In stent restenosis; Intravascular ultrasound; Minimum stent area; Peripheral artery disease; Restenosis; Self expanding nitinol stent; Superficial femoral artery

Indexed keywords

PACLITAXEL; ALLOY; CARDIOVASCULAR AGENT; NITINOL;

AGED; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTICLE; BALLOON DILATATION; CHRONIC TOTAL OCCLUSION; CRITICAL LIMB ISCHEMIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; NITINOL STENT; PHYSICAL PARAMETERS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STENT DIMENSION; SUPERFICIAL FEMORAL ARTERY; ADVERSE EFFECTS; AREA UNDER THE CURVE; CHI SQUARE DISTRIBUTION; DEVICES; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; FEMORAL ARTERY; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; PROSTHESIS DESIGN; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TIME FACTOR; TREATMENT OUTCOME; VASCULAR PATENCY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLOYS; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; AREA UNDER CURVE; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; FEMALE; FEMORAL ARTERY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 85012910909     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1177/1526602816641669     Document Type: Article

References (38)

1. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888.
2. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
3. Iida O, Takahara M, Soga Y, et al. 1-year results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): predictors of restenosis. JACC Cardiovasc Interv. 2015;8:1105-1112.
4. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745-2749.
5. Iida O, Yokoi H, Soga Y, et al. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation. 2013;127:2307-2315.
6. Costa MA, Simon DI. Molecular basis of restenosis and drugeluting stents. Circulation. 2005;111:2257-2273.
7. Forrester JS, Fishbein M, Helfant R, et al. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17:758-769.
8. Tobis JM, Mallery J, Mahon D, et al. Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation. 1991;83:913-926.
9. Arthurs ZM, Bishop PD, Feiten LE, et al. Evaluation of peripheral atherosclerosis: A comparative analysis of angiography and intravascular ultrasound imaging. J Vasc Surg. 2010;51:933-938.
10. Oemrawsingh PV, Mintz GS, Schalij MJ, et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation. 2003;107:62-67.
11. Iida O, Takahara M, Soga Y, et al. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery. JACC Cardiovasc Interv. 2014;7:792-798.
12. Kastrati A, Schömig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30:1428-1436.
13. Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis. J Am Coll Cardiol. 1995;26:720-724.
14. Kawarada O, Higashimori A, Noguchi M, et al. Duplex criteria for in-stent restenosis in the superficial femoral artery. Catheter Cardiovasc Interv. 2013;81:E199-E205.
15. Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation. 2003;108:43-47.
16. Tanabe K, Serruys PW, Degertekin M, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation. 2005;111:900-905.
17. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478-1492.
18. Choi SY, Maehara A, Cristea E, et al. Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy). Am J Cardiol. 2012;109:455-460.
19. Hoffmann R, Mintz GS, Mehran R, et al. Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. J Am Coll Cardiol. 1998;31:43-49.
20. Hoffmann R, Mintz GS, Pichard AD, et al. Intimal hyperplasia thickness at follow-up is independent of stent size: A serial intravascular ultrasound study. Am J Cardiol. 1998;82:1168-1172.
21. Kuntz RE, Gibson CM, Nobuyoshi M, et al. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 1993;21:15-25.
22. Nakamura S, Colombo A, Gaglione A, et al. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89:2026-2034.
23. León LR Jr, Dieter RS, Gadd CL, et al. Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery. J Vasc Surg. 2013;57:1014-1022.
24. Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10:861-868.
25. Maehara A, Mintz GS, Shimshak TM, et al. Intravascular ultrasound evaluation of JETSTREAM atherectomy removal of superficial calcium in peripheral arteries. EuroIntervention. 2015;11:96-103.
26. Shammas NW, Coiner D, Shammas GA, et al. Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. J Vasc Interv Radiol. 2011;22:1223-1228.
27. Dake MD, Ansel GM, Jaff MR, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. 2013;61:2417-2427.
28. Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495-504.
29. Axel DI, Kunert W, Göggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636-645.
30. Sollott SJ, Cheng L, Pauly RR, et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest. 1995;95:1869-1876.
31. Nishida T, Colombo A, Briguori C, et al. Outcome of nonobstructive residual dissections detected by intravascular ultrasound following percutaneous coronary intervention. Am J Cardiol. 2002;89:1257-1262.
32. Sheris SJ, Canos MR, Weissman NJ. Natural history of intravascular ultrasound-detected edge dissections from coronary stent deployment. Am Heart J. 2000;139:59-63.
33. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992;18:433-440.
34. Diehm N, Baumgartner I, Jaff M, et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J. 2007;28:798-805.
35. Rocha-Singh KJ, Jaff MR, Crabtree TR, et al. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910-919.
36. Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol. 2004;43:1959-1963.
37. Doi H, Maehara A, Mintz GS, , et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv. 2009;2:1269-1275.
38. Yang TH, Kim DI, Jin HY, et al. "Angiographic late catchup" phenomenon after sirolimus-eluting stent implantation. Int J Cardiol. 2012;160:48-52.